Back to top

Is CHRS positioned for a breakout? MACD Bullish Signal Line Cross shows up after advancing 2.13%

Coherus BioSciences, Inc. (CHRS) — Nightly Technical Analysis · Aug 3, 2026, 20:06 ET
CHRS posted a 2.13% gain on Monday, August 3rd, accompanied by 0.6× normal trading volume. consolidation patterns formed: NR7, suggesting a potential continuation after price stabilization. Key support levels exist at 1.42, 1.39 & 1.37, with resistance at 1.46, 1.48 & 1.51.

Current SwingTradeBot Technical Rating of CHRS: D

Want the complete picture? Head to SwingTradeBot to see the rest of today’s action.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Coherus Oncology, Inc. (CHRS)